ArticleBMC ophthalmology2025
Xeno-ADM combined with inferior eyelid margin fixation to treat entropion accompanied by lower eyelid retraction.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo report the efficacy of "Xeno-ADM combined with inferior eyelid margin fixation" for entropion accompanied by lower eyelid retraction.
methodsA retrospective review of 28 patients (48 eyes) diagnosed with lower eyelid entropion accompanied by lower eyelid retraction was performed. The follow-up period lasted more than 6 months. MRD2, angle between the eyelashes and the corneal surface, ocular discomfort symptoms, and complications were recorded and used to evaluate the efficacy and safety.
resultsTwenty eight patients (48 eyes) were included, within 6 months after surgery, 45 eyes (93.75%) had complete relief from ocular discomfort, while 3 eyes (6.3%) showed partial improvement; 48 eyes (100%) had complete resolution of the foreign body sensation; 15 eyes (83.3%) had complete relief from lacrimation, and 3 eyes (16.7%) showed partial improvement, MRD2 was from 7.2 (7.0, 7.5) mm to 5.5 (5.0, 5.5) mm (Z = -3.995, P < 0.01). The angle between the eyelashes and the cornea was from 36.76 (32.18, 38.49) to 68.23 (67.30, 70.31) (Z = -6.031, P < 0.01). And no other complications, such as infection, rejection, and dislocation, were observed.
conclusionXeno-ADM combined with inferior eyelid margin fixation is reasonably successful in managing entropion accompanied by lower eyelid retraction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.